Rating History for Summit Therapeutics plc (SMMT) by Bernstein SocGen Group
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/25/2026 | Jeffrey Walch | Upgrade | Market Perform (Underperform) |
11.90 (9.80) |
13.16 (17.54) |
33.28% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
